Interleukin-18 (IL18) is an important proinflammatory cytokine involved in the pathogenesis of acute coronary events and type 2 diabetes mellitus [17], and it is associated with the modification of obesity and metabolic syndrome risk, although the underlying mechanisms remain unclear [18]. This evidence concerns the gene IL18 and diabetes mellitus.